Experience with intraperitoneal cisplatin and etoposide and i.v. thiosulphate protection in ovarian cancer patients with either pathologically complete response or minimal residual disease

R.E.N. van Rijswijk, K. Hoekman, C.W. Burger, RHM Verheijen, J.B. Vermorken

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1235-1241
JournalAnnals of Oncology
Publication statusPublished - 1997

Cite this